Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D1N2BO
|
|||
| Drug Name |
GSK'963
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Myeloid leukaemia [ICD-11: 2B33.1; ICD-9: 208.9] | Investigative | [1] | |
| Company |
GlaxoSmithKline
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Receptor-interacting protein 1 (RIPK1) | Target Info | Inhibitor | [1] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Characterization of GSK'963: a structurally distinct, potent and selective inhibitor of RIP1 kinase. Cell Death Discov. 2015 Jul 27;1:15009. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.